Disparities in Prescription of Opioids Among Prostate Cancer Patients of Various Racial Groups

Abstract

Aim: To examine disparities in opioid prescription between different races of prostate cancer patients. Materials & methods: We used the Medical Expenditure Panel Survey data (2013–2015) and developed a model based on covariates that may affect opioid prescription and based on this model, we carried out logistic regression, where our outcome of interest was prescription of at least one opioid among prostate cancer patients. Results: Compared with non-Hispanic whites, Hispanics had 0.490 (0.214–1.123), non-Hispanics blacks had 0.745 (0.429–1.293) and other ethnic groups had 2.550 (0.947–6.863) times the odds of receiving opioids than non-Hispanic whites. These differences were not statistically significant. Conclusion: There were no differences between races in terms of opioid prescription for patients with prostate cancer.

Keywords::

• disparities
• medical expenditure panel survey
• MEPS
• opioids
• prostate cancer
• racial

Supplementary data

To view the supplementary data that accompany this paper please visit the journal website at: www.tandfonline.com/doi/full/10.2217/pmt-2018-0076

Financial & competing interests disclosure

The authors have no relevant affiliations or financial involvement with any organization or entity with a financial interest in or financial conflict with the subject matter or materials discussed in the manuscript. This includes employment, consultancies, honoraria, stock ownership or options, expert testimony, grants or patents received or pending, or royalties.

No writing assistance was utilized in the production of this manuscript.